• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APYX MEDICAL CORPRATION J-PLASMA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APYX MEDICAL CORPRATION J-PLASMA Back to Search Results
Model Number BVX-270B
Medical Device Problem Code Use of Device Problem (1670)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 01/24/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The subsequent investigation of the returned device and extensive internal testing has ruled out this type of damage as occurring during the manufacturing or shipping processes.This issue was most likely caused by inadvertent damage to the distal end of the shaft caused by the user either during clinical use or while removing coagulum/eschar from the electrode.Skin ports were used at the incision site that could result in damage at the distal end of the handpiece due to the tight interference with the outer diameter of the shaft of the device.The damage seen during clinical use may also have been caused by one or a combination of the following factors: (1) subjecting the device to unknown solvents, chemicals or disinfectants or any additional cleaning or reuses that may compromise essential material and design characteristics as well as the structural integrity of the device and lead to device failure, (2) use of a scratch pad (commonly available in surgical environments) or other abrasive materials to clean the blade, and/or (3) modifying or altering the tip of the device.The ifu gives cleaning instructions to avoid any type of abrasive damage "for optimum performance, keep the distal end of the shaft free of debris.A damp gauze pad can be used for cleaning." as well as instructions to avoid recleaning, resterilization or reuse.Note: when this incident was first reported, there were no patient injuries and based on the investigation, there was no malfunction.Due to subsequent reports of this issue occurring during clinical use in the past 30 days, it is being reported retrospectively, as it is now included as part of the field action being initiated.
 
Event or Problem Description
During clinical use, an unexpected stress fracture occurred on the shaft of the handpiece resulting in fragmentation.The issue was recognized by the user and the physician completed the procedure with another device.There was no injury to the patient or physician.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
J-PLASMA
Common Device Name
J-PLASMA
Manufacturer (Section D)
APYX MEDICAL CORPRATION
5115 ulmerton road
clearwater, fl
MDR Report Key9989958
Report Number3007593903-2020-00013
Device Sequence Number4597518
Product Code GEI
UDI-Device Identifier00607151009458
UDI-Public00607151009458
Combination Product (Y/N)N
Initial Reporter CountryCO
PMA/510(K) Number
K151325
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source distributor
Initial Reporter Occupation Non-Healthcare Professional
Remedial Action Recall,Notification
Type of Report Initial
Report Date (Section B) 04/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/01/2022
Device Model NumberBVX-270B
Device Catalogue NumberBVX-270B
Device Lot Number1019B
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/06/2020
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/20/2020
Initial Report FDA Received Date04/23/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
3007593903-04/28/20-001C
Patient Sequence Number1
Patient Age29 YR
-
-